Literature DB >> 9500901

T1 effects in sequential dynamic susceptibility contrast experiments.

J M Levin1, L L Wald, M J Kaufman, M H Ross, L C Maas, P F Renshaw.   

Abstract

Residual effects of an initial bolus of gadolinium contrast agent have been previously demonstrated in sequential dynamic susceptibility contrast MR experiments. While these residual effects quickly reach a saturation steady state, their etiology is uncertain, and they can lead to spurious estimates of hemodynamic parameters in activation experiments. The possible influence of T1 effects is now investigated with experiments in which T1 weighting is varied as well as with serial regional T1 measurements. Little evidence for significant residual T1 effects is found, suggesting instead that susceptibility effects underlie these observations. An initial saturation dose of contrast agent minimizes this effect. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500901     DOI: 10.1006/jmre.1997.1317

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  7 in total

1.  Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain.

Authors:  R Mangla; B Kolar; T Zhu; J Zhong; J Almast; S Ekholm
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

2.  Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine.

Authors:  Jody Tanabe; Thomas Crowley; Kent Hutchison; David Miller; Glyn Johnson; Yiping P Du; Gary Zerbe; Robert Freedman
Journal:  Neuropsychopharmacology       Date:  2007-04-25       Impact factor: 7.853

3.  Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Ramon F Barajas; Jamie S Chang; Mark R Segal; Andrew T Parsa; Michael W McDermott; Mitchel S Berger; Soonmee Cha
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

4.  Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.

Authors:  Andrés Server; Tone E Døli Orheim; Bjørn A Graff; Roger Josefsen; Theresa Kumar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-07-13       Impact factor: 2.804

5.  Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors.

Authors:  M Vittoria Spampinato; Caroline Wooten; Margaret Dorlon; Nada Besenski; Zoran Rumboldt
Journal:  Neuroradiology       Date:  2006-09-30       Impact factor: 2.804

6.  Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor grading.

Authors:  Andrés Server; Bjørn A Graff; Tone E Døli Orheim; Till Schellhorn; Roger Josefsen; Øystein B Gadmar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-09-21       Impact factor: 2.804

7.  Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.

Authors:  Young Jin Heo; Ho Sung Kim; Ji Eun Park; Choong-Gon Choi; Sang Joon Kim
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.